Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)

SHA:600557 Revenue

Jiangsu Kanion Pharmaceutical had revenue of 761.07M CNY in the quarter ending September 30, 2026, with 8.55% growth. This brings the company's total for the last twelve months to 3.37B, up 7.63% year-over-year. In the year 2025, Jiangsu Kanion Pharmaceutical had annual revenue of 3.29B, down -15.52%. That makes Jiangsu Kanion Pharmaceutical the 11,216th largest company in the world by revenue and 1,877th in China.

• Revenue (ttm): 3.37B
• Revenue Growth: +7.63%
• P/S Ratio: 2.01
• Revenue / Employee: 627.03K
• Employees: 5,379
• Market Cap: 6.77B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.29B	-604.77M	-15.52%
Dec 31, 2024	3.90B	-966.15M	-19.86%
Dec 31, 2023	4.86B	512.95M	11.79%
Dec 31, 2022	4.35B	702.30M	19.25%
Dec 31, 2021	3.65B	616.64M	20.34%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error